|
COPYRIGHT 2006 International Medical News Group
Paroxetine may increase the risk of suicidal behavior in adults, particularly in young adults, findings from a recent metaanalysis suggest.
"It is therefore important that all patients, especially young adults and those who are improving, receive careful monitoring during paroxetine therapy regardless of the condition being treated," the Food and Drug Administration and GlaxoSmithKline, the drug's maker and the sponsor of the study, stated in a "Dear Healthcare Provider" letter announcing a related update to the warnings section of the drug's label.
The metaanalysis, which included data...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
